For over 1 million adults and children in the United States who suffer from inflammatory bowel disease (IBD), symptoms such as abdominal pain, digestive issues, weight loss and fatigue are an uncomfortable way of life, even with treatment. IBD (a term for two conditions, Crohn’s disease and ulcerative colitis), shows up as chronic inflammation of the gastrointestinal tract. The exact cause of IBD is unknown, but the disease results from a defective immune system.
Trending
- Are we sleepwalking into AI disruption in GI?
- AI Digital Twins Are Helping People Manage Diabetes and Obesity (WIRED)
- 3 Healthcare Threats That Will Soon Become Too Big To Solve (Forbes)
- From GLP-1s to engineered probiotics: New research highlights evolving IBD care (AGA)
- Physician consolidation squeeze: Rising costs and tight cash flow are reshaping practice growth (Physicians Practice)
- The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health (Nature Reviews Gastroenterology & Hepatology)
- Medical Malpractice: Staying Out of Trouble (GI & Endoscopy News)
- Evaluating Benefits of AI During Colonoscopy (GI & Endoscopy News)
